147 related articles for article (PubMed ID: 2149045)
21. Efficacy of teicoplanin for enterococcal infections: 63 cases and review.
Schmit JL
Clin Infect Dis; 1992 Aug; 15(2):302-6. PubMed ID: 1387808
[TBL] [Abstract][Full Text] [Related]
22. Teicoplanin therapy in children: a review.
Bassetti D; Cruciani M
Scand J Infect Dis Suppl; 1990; 72():35-7. PubMed ID: 2151065
[TBL] [Abstract][Full Text] [Related]
23. Beta-lactam versus beta-lactam-aminoglycoside combination therapy in cancer patients with neutropaenia.
Paul M; Soares-Weiser K; Grozinsky S; Leibovici L
Cochrane Database Syst Rev; 2002; (2):CD003038. PubMed ID: 12076467
[TBL] [Abstract][Full Text] [Related]
24. [Febrile neutropenia: empiric antibiotic therapy from 1975 to 1997].
Klastersky J
Rev Med Brux; 1997 Oct; 18(5):323-7. PubMed ID: 9441328
[TBL] [Abstract][Full Text] [Related]
25. β-lactam antibiotic versus combined β-lactam antibiotics and single daily dosing regimens of aminoglycosides for treating serious infections: A meta-analysis.
Heffernan AJ; Sime FB; Sun J; Lipman J; Kumar A; Andrews K; Ellwood D; Grimwood K; Roberts J
Int J Antimicrob Agents; 2020 Mar; 55(3):105839. PubMed ID: 31704215
[TBL] [Abstract][Full Text] [Related]
26. [Empirical treatment of febrile episodes in patients with neutropenia in bone marrow transplantation].
Pérez M; Muruzábal MJ; Gómez Casares MT; Alsar MJ; Conde E; Iriondo A; Garijo J; Richard C; Baro J; Aguado JM
Enferm Infecc Microbiol Clin; 1990 Oct; 8(8):490-5. PubMed ID: 2095260
[TBL] [Abstract][Full Text] [Related]
27. Intravenous and oral mono- or combination-therapy in the treatment of severe infections: ciprofloxacin versus standard antibiotic therapy. Ciprofloxacin Study Group.
Krumpe PE; Cohn S; Garreltes J; Ramirez J; Coulter H; Haverstock D; Echols R
J Antimicrob Chemother; 1999 Mar; 43 Suppl A():117-28. PubMed ID: 10225582
[TBL] [Abstract][Full Text] [Related]
28. A comparative efficacy and safety study of teicoplanin plus aztreonam versus gentamicin plus piperacillin in haematology oncology patients with clinically diagnosed septicaemia.
Spencer RC; Taylor AK; Winfield DA
Br J Haematol; 1990 Dec; 76 Suppl 2():30-4. PubMed ID: 2149049
[TBL] [Abstract][Full Text] [Related]
29. Intravenous or intramuscular teicoplanin once daily for skin and soft-tissue infections.
Edelstein HE; Oster SE; Chirurgi VA; Karp RA; Cassano KB; McCabe RE
DICP; 1991 Sep; 25(9):914-8. PubMed ID: 1835223
[TBL] [Abstract][Full Text] [Related]
30. A randomized study of teicoplanin plus ciprofloxacin versus gentamicin plus piperacillin for the empirical treatment of fever in neutropenic patients.
Kelsey SM; Collins PW; Delord C; Weinhard B; Newland AC
Br J Haematol; 1990 Dec; 76 Suppl 2():10-3. PubMed ID: 2149044
[TBL] [Abstract][Full Text] [Related]
31. The use of aminoglycosides in neutropenic patients.
Cometta A; Glauser MP
Schweiz Med Wochenschr Suppl; 1996; 76():21S-27S. PubMed ID: 8677415
[TBL] [Abstract][Full Text] [Related]
32. The role of gram-positive therapy in the neutropenic patient.
Menichetti F; Del Favero A
J Antimicrob Chemother; 1991 Apr; 27 Suppl B():51-60. PubMed ID: 1829077
[TBL] [Abstract][Full Text] [Related]
33. [The use of teicoplanin in neutropenic patients: values and limits].
Espinouse D; Chomarat M
Pathol Biol (Paris); 1990 Jun; 38(5 ( Pt 2)):552-6. PubMed ID: 2143573
[TBL] [Abstract][Full Text] [Related]
34. Use of a glycopeptide antibiotic, teicoplanin, in the treatment of septicaemia caused by gram-positive bacteria.
Webster A; Wilson AP; Treasure T; Grüneberg RN
Int J Clin Pharmacol Res; 1988; 8(2):95-8. PubMed ID: 2967800
[TBL] [Abstract][Full Text] [Related]
35. [A comparative review of combination therapy: 2 beta-lactams versus beta-lactam plus aminoglycoside].
Dejace P; Klastersky J
Infection; 1987; 15 Suppl 4():S158-67. PubMed ID: 3312028
[TBL] [Abstract][Full Text] [Related]
36. Clinical efficacy and safety of teicoplanin.
Stille W; Sietzen W; Dieterich HA; Fell JJ
J Antimicrob Chemother; 1988 Jan; 21 Suppl A():69-79. PubMed ID: 2965134
[TBL] [Abstract][Full Text] [Related]
37. [Teicoplanin and Gram-positive coccus infections. Results of a multicenter study on 66 cases].
Dureux JB; Canton P; Chavanet P; Chippaux C; Dupeyron JP; Estavoyer JM; Giorgi C; Jaeger A; Jehl F; Kazmierzack A
Pathol Biol (Paris); 1987 May; 35(5):511-5. PubMed ID: 2956564
[TBL] [Abstract][Full Text] [Related]
38. [Imipenem combined with teicoplanin or vancomycin in the initial empirical treatment of febrile neutropenia. Analysis of the primary response and of a global sequential strategy in 126 episodes].
Figuera A; Tomás JF; Hernández L; Jiménez ML; Peñarrubia MJ; del Rey MC; Arranz R; Cámara R; López-Lorenzo JL; Fernández-Rañada JM
Rev Clin Esp; 1996 Aug; 196(8):515-22. PubMed ID: 8984537
[TBL] [Abstract][Full Text] [Related]
39. Ceftazidime as monotherapy or combined with teicoplanin for initial empiric treatment of presumed bacteremia in febrile granulocytopenic patients.
Nováková I; Donnelly JP; De Pauw B
Antimicrob Agents Chemother; 1991 Apr; 35(4):672-8. PubMed ID: 1829879
[TBL] [Abstract][Full Text] [Related]
40. Teicoplanin in the treatment of skin and soft tissue infections: results of a multicentre study.
Lang E; Földes M; Marghescu S
Infection; 1991; 19(3):190-4. PubMed ID: 1832418
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
